Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach

M L Urban1, A Palmisano1, M Nicastro1

  • 1Unit of nephrology, university hospital, Parma, Italy.

La Revue De Medecine Interne
|December 3, 2014
PubMed

Insights

Retroperitoneal fibrosis (RPF) is a rare condition causing ureteral obstruction. Differentiating between idiopathic, IgG4-related, and secondary RPF is vital for effective treatment strategies.

Area of Science:

  • Nephrology
  • Immunology
  • Oncology

Background:

  • Retroperitoneal fibrosis (RPF) is a rare condition involving fibrous tissue growth in the retroperitoneum.
  • It frequently leads to ureteral entrapment and obstructive uropathy.
  • RPF can be idiopathic, or secondary to malignancies, infections, drugs, radiotherapy, or Erdheim-Chester disease.

Purpose of the Study:

  • To review the clinical, laboratory, and imaging features of various RPF forms.
  • To highlight the importance of differential diagnosis between idiopathic, IgG4-related, and secondary RPF.
  • To provide an overview of current treatment options for RPF.

Main Methods:

  • Literature review of clinical presentations, diagnostic criteria, and therapeutic approaches for RPF.
  • Analysis of differentiating factors between idiopathic RPF, IgG4-related disease, and secondary causes of RPF.
  • Synthesis of information on diagnostic tools including imaging and laboratory tests.

Main Results:

  • Idiopathic RPF is often immune-mediated, potentially isolated or associated with autoimmune conditions or IgG4-related disease.
  • Secondary RPF has diverse etiologies including cancer, infection, and iatrogenic causes.
  • Accurate diagnosis is critical as treatment varies significantly between RPF subtypes.

Conclusions:

  • Distinguishing between RPF subtypes is essential for guiding appropriate patient management.
  • Understanding the underlying cause of RPF dictates the therapeutic strategy.
  • This review provides a comprehensive overview for clinicians managing patients with RPF.